UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma

Phase 2

Terminated

Conditions: Cancer

Interventions: Drug: SOM230B

First Posted Date: 2008-12-23

Last Posted Date: 2014-06-11

Lead Sponsor: University of Utah

Target Recruit Count: 2

Registration Number: NCT00813592

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Multi-Tracer PET Assessment of Primary Brain Tumors

Phase 1

Completed

Conditions: Brain Tumors
Cancer

Interventions: Drug: [18F]fluoro-2-deoxy-D-glucose (FDG)
Drug: 3'-deoxy-3'-[18F]fluorothymidine (FLT)
Drug: [15O]-H2O
Drug: [11C]Acetate

First Posted Date: 2008-12-23

Last Posted Date: 2022-04-27

Lead Sponsor: University of Utah

Target Recruit Count: 11

Registration Number: NCT00813566

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

Phase 2

Terminated

Conditions: Peutz-Jeghers Syndrome

Interventions: Drug: Everolimus

First Posted Date: 2008-12-19

Last Posted Date: 2013-07-26

Lead Sponsor: University of Utah

Target Recruit Count: 3

Registration Number: NCT00811590

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents

Completed

Conditions: Sepsis

Interventions: Drug: Linezolid or Vancomycin

First Posted Date: 2008-12-19

Last Posted Date: 2011-11-24

Lead Sponsor: University of Utah

Target Recruit Count: 60

Registration Number: NCT00811980

Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

Completed

Conditions: Venous Thromboembolism

Interventions: Behavioral: Education

First Posted Date: 2008-12-18

Last Posted Date: 2008-12-18

Lead Sponsor: University of Utah

Target Recruit Count: 121

Registration Number: NCT00810784

Locations: 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States

Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly

Early Phase 1

Terminated

Conditions: Alzheimer's Disease

First Posted Date: 2008-12-18

Last Posted Date: 2023-04-24

Lead Sponsor: University of Utah

Target Recruit Count: 2

Registration Number: NCT00811122

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart Failure

Phase 4

Completed

Conditions: Heart Failure

Interventions: Drug: Terbutaline Infusion

First Posted Date: 2008-12-04

Last Posted Date: 2023-11-08

Lead Sponsor: University of Utah

Target Recruit Count: 25

Registration Number: NCT00802230

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants

Completed

Conditions: Patent Ductus Arteriosus

First Posted Date: 2008-11-24

Last Posted Date: 2014-12-05

Lead Sponsor: University of Utah

Target Recruit Count: 350

Registration Number: NCT00795990

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

Phase 2

Completed

Conditions: Acute Leukaemia
Myelodysplasia
Chronic Disease
Leukemia
Lymphoma

Interventions: Drug: Busulfan
Drug: Anti-Thymocyte Globulin
Drug: Fludarabine
Drug: Cyclosporine
Drug: Mycophenolate mofetil

First Posted Date: 2008-11-21

Last Posted Date: 2013-07-30

Lead Sponsor: University of Utah

Target Recruit Count: 47

Registration Number: NCT00795132

Locations: 🇺🇸
Primary Children's Medical Center, Salt Lake City, Utah, United States

Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

Phase 2

Completed

Conditions: Acute Lymphoblastic Leukemia

Interventions: Drug: RAPAMYCIN

First Posted Date: 2008-11-21

Last Posted Date: 2013-07-31

Lead Sponsor: University of Utah

Target Recruit Count: 63

Registration Number: NCT00795886

Locations: 🇺🇸
Primary Children's Medical Center, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy